OTC Watch

All stocks / YBGJ

Yubo International Biotech Ltd YBGJ

Yubo International Biotech (YBGJ): shares outstanding up 42% in a year and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated float OTCIDChina
Live quote on OTC Markets

Market listing

Full name
YUBO INTL BIOTECH LTD
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 13
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$12,353
Net loss
($1,079,248)
What it means

It spends more than it earns

Under strain

Customers paid it $12,353 in the year. It lost $1.1 million. For every $1 that came in, about $88.37 went out.

The report says
Cash and cash equivalents
$8,062
Net cash used in operating activities
($842,802)
What it means

The cash could run out soon

Under strain

It had $8,062 in the bank and used about $70,234 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$847,094
Total liabilities
$2,791,297
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $847,094. Its debts and unpaid bills add up to $2.8 million. That is about $3.30 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-03-25

Shares outstanding rose from 119,816,343 (2025-03-31) to 170,416,343 (2026-03-25), up 42%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-03-25

Estimated float about 170,416,343 shares as of 2026-03-25: 170,416,343 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2024-05-17
119.8M
2024-08-16
119.8M
2024-11-10
119.8M
2025-03-31
119.8M
2025-05-14
119.8M
2025-08-13
170.4M
2025-11-13
170.4M
2026-03-25
170.4M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-10 10-QFORM 10-Q
2026-08-14 10-QFORM 10-Q
2026-06-12 DEF 14CDEF 14C
2026-06-12 ARSARS
2026-05-15 10-QFORM 10-Q
2026-03-31 10-KFORM 10-K
2026-01-16 8-KFORM 8-K

Common questions about YBGJ

Does YBGJ file reports with the SEC?

Yes. Yubo International Biotech files with the SEC under company number 0000895464. The most recent filing we hold is a 10-Q dated 2026-11-10.

Source record

How many YBGJ shares are outstanding?

170,416,343 shares as of 2026-03-25, as reported to the SEC. That is up 42% from 119,816,343 on 2025-03-31.

Source record

Has YBGJ filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is Yubo International Biotech making money?

Customers paid it $12,353 in the year. It lost $1.1 million. For every $1 that came in, about $88.37 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record